Keryx Biopharmaceuticals Inc. Company Profile | StatInvestor

Health Care & Life Sciences » Biotechnology | Keryx Biopharmaceuticals Inc.

Keryx Biopharmaceuticals Inc.

Keryx Biopharmaceuticals Inc.
Stock Exchange	Frankfurt Stock Exchange
EPS	-
Market Cap	-
Shares Outstanding	120.46 M
Public Float	94.02 M

Keryx Biopharmaceuticals Inc.
Stock Exchange	NASDAQ Stock Market
EPS	$0.82
Market Cap	$361.38 M
Shares Outstanding	120.46 M
Public Float	118.59 M

Profile

Address	12th Floor Boston Massachusetts 02210 United States
Employees	-
Website	http://www.keryx.com
Updated	09/14/2018
Keryx Biopharmaceuticals, Inc. engages in the manufacture, development, and commercialization of medicines for use in treating human diseases. Its product is the Auryxia tablet. The company was founded in October 1998 and is headquartered in Boston, MA.

Financials

Jodie P. Morrison

Interim Chief Executive Officer & Director

Michael W. Rogers

Chairman